Satya @ JPM 2024
Satya had meetings with potential partners and collaborators to discuss its portfolio of programs during the JPM. A number of programs and collaboration ideas were discussed and would expand our agenda for 2024 and beyond.
An Oncology biotech pioneering RAD51 inhibition and other DDR mechanisms
